February 2020:Terumo Cardiovascular Group announced that it has come into a three-year exclusive distribution agreement with Hemostasis, LLCthat will bring BoneSeal® bone hemostat to the United States cardiac surgery market.BoneSeal® bone hemostat is used as a mechanical barrier to control bleeding from a cut or damaged bone surfaces.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?